Page last updated: 2024-10-30

losartan and IgA Vasculitis

losartan has been researched along with IgA Vasculitis in 2 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

IgA Vasculitis: A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosch, X1
Brouard, M1
Piguet, V1
Chavaz, P1
Borradori, L1

Other Studies

2 other studies available for losartan and IgA Vasculitis

ArticleYear
Henoch-Schönlein purpura induced by losartan therapy.
    Archives of internal medicine, 1998, Jan-26, Volume: 158, Issue:2

    Topics: Antihypertensive Agents; Humans; IgA Vasculitis; Losartan; Male; Middle Aged

1998
Schönlein-Henoch purpura associated with losartan treatment and presence of antineutrophil cytoplasmic antibodies of x specificity.
    The British journal of dermatology, 2001, Volume: 145, Issue:2

    Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Antihypertensive Agents; Female; Humans; IgA Vasculiti

2001